MedTrace Logo

Quantitative D-dimer Level and Anticoagulant Therapy in Idiopathic Intracranial Hypertension

NCT03963336 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2019-05-24

No results posted yet for this study

Summary

Idiopathic intracranial hypertension (IIH) is a syndrome characterized by elevated intracranial pressure (ICP) of unknown etiology.

The investigators aim to study the quantitative D-dimer level and the role of anticoagulant therapy in the absence of occlusive sinus thrombosis in IIH patients.

Conditions

  • Idiopathic Intracranial Hypertension

Interventions

DRUG

LMWH

Subcutaneous LMWH 1mg/kg/day for 2 weeks

DRUG

acetazolamide

Carbonic anhydrase inhibitor 1-2g/day for 6 months

Sponsors & Collaborators

  • Fayoum University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-07-22
Primary Completion
2018-07-23
Completion
2018-08-02

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03963336 on ClinicalTrials.gov